V.F. Corp.'s Q3 fiscal 2025 earnings exceeded expectations, yet shares fell 4% after initial euphoria. Read why I remain neutral on VFC stock.
Sanofi (NASDAQ:SNY) reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and a solid increase in earnings per share (EPS). The company's net sales rose ...